RASGRP2 promotes doxorubicin chemoresistance and tumor progression in osteosarcoma via the Notch1-NICD-Hes1 axis. // Tissue and Cell. – URL: https://www.sciencedirect.com/science/article/pii/S0040816626007561?dgcid=rss_sd_all
RASGRP2 promotes doxorubicin chemoresistance and tumor progression in osteosarcoma via the Notch1-NICD-Hes1 axis. Tissue and Cell. https://www.sciencedirect.com/science/article/pii/S0040816626007561?dgcid=rss_sd_all
“RASGRP2 promotes doxorubicin chemoresistance and tumor progression in osteosarcoma via the Notch1-NICD-Hes1 axis.” Tissue and Cell.
@article{article119739,
title = {RASGRP2 promotes doxorubicin chemoresistance and tumor progression in osteosarcoma via the Notch1-NICD-Hes1 axis},
journal = {Tissue and Cell},
url = {https://www.sciencedirect.com/science/article/pii/S0040816626007561?dgcid=rss_sd_all}
}